A PYMNTS Company

US: CVS purchase of Aetna gets final approval

By  |  September 5, 2019

CVS Health’s nearly US$70 billion acquisition of health insurer Aetna was given final approval by a Federal judge after a condition set by the Justice Department was achieved.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The merger was allowed on condition Aetna sell its Medicare prescription drug plan business to WellCare Health Plans and both deals have already closed.

    US District Judge Richard Leon had questioned whether the settlement did enough to protect competition and consumers in health-care markets.

    Judge Leon said on Wednesday, September 4, that the health care markets at issue in the case “are not only very competitive today, but are likely to remain so post-merger.”  The settlement “is well within the reaches of the public interest,” the judge concluded, according to Dow Jones.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.